IMMUPHARMA

 

Latest News

Lupuzor founder awarded 'CNRS Medal of Innovation'

ImmuPharma has announced that Dr Sylviane Muller the key inventor of Lupuzor and research director at Centre Natio...

Lupuzor's Founder Dr Slyviane Muller Awarded Medal

RNS Number: 1580R Immupharma PLC 25 June 2015 ImmuPharma PLC 25 JUNE 2015 Lupuzor's Founder, Dr Slyviane Muller - Awarded Medal of Innovation from CNRS for Lupuzor ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company is delighted to announce that Dr Sylviane Muller th...

ImmuPharma resolutions passed at AGM

ImmuPharma has confirmed that all resolutions proposed at the annual general meeting today were passed. At 1:00pm: (LO...

Result of AGM

RNS Number: 6736O Immupharma PLC 29 May 2015 FOR IMMEDIATE RELEASE 29 MAY 2015 ANNUAL GENERAL MEETING: 2015 ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed. A sum...

All News

DateHeadlineSource
25-06-15Lupuzor founder awarded 'CNRS Medal of Innovation'StockMarketWire
25-06-15Lupuzor's Founder Dr Slyviane Muller Awarded MedalRNS
29-05-15ImmuPharma resolutions passed at AGMStockMarketWire
29-05-15Result of AGMRNS
06-05-15Annual Report & AccountsRNS
06-05-15ImmuPharma appoints interim chairman StockMarketWire
06-05-15Interim Board ChangeRNS
30-04-15ImmuPharma losses narrow StockMarketWire
30-04-15Directorate ChangeRNS
30-04-15Preliminary ResultsRNS
11-02-15Immupharma completes clinical trial StockMarketWire
11-02-15CANCER UPDATE: IPP-204106RNS
27-01-15ImmuPharma gets assurance over EIS StockMarketWire
27-01-15Enterprise Investment Scheme StatusRNS
22-01-15FTSE surges as ECB unveils QE, financials riseStockMarketWire
22-01-15FTSE cautiously up as ECB's QE call nearsStockMarketWire
22-01-15Collaboration Agreement with Simbec-OrionRNS
30-10-14Holding(s) in CompanyRNS
28-10-14Holding(s) in CompanyRNS
21-10-14FTSE 100 makes strong recoveryStockMarketWire
21-10-14FTSE 100 bounces backStockMarketWire
21-10-14ImmuPharma raises £3.4m StockMarketWire
21-10-14Additional Listing - Conditional PlacingRNS
20-10-14ImmuPharma unit awarded €400,000 grant StockMarketWire
20-10-14ImmuPharma awarded EUR400,000 GrantRNS
30-09-14Losses remain at ImmuPharmaStockMarketWire
30-09-14Half Yearly ReportRNS
30-09-14LupuzorT Gears Up To Start Pivotal Phase III trialRNS
27-06-14Immupharma shareholders approve AGM resolutionsStockMarketWire
27-06-14Result of AGMRNS
27-06-14ImmuPharma extends research capabilitiesStockMarketWire
27-06-14Access to pioneering research in Bordeaux FranceRNS
16-06-14ImmuPharma granted new Nucant patents StockMarketWire
16-06-14NEW NUCANT PATENTSRNS
23-05-14Annual Financial ReportRNS
21-05-14ImmuPharma pre-tax losses riseStockMarketWire
21-05-14Preliminary ResultsRNS
06-05-14ImmuPharma gives summary from lupus conference StockMarketWire
06-05-14Dr. Sylviane Muller - Presentation AbstractRNS
23-04-14Lupuzor founder presents at Osaka UniversityStockMarketWire

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory